580,000 bottles of a blood pressure drug recalled over cancer risk, FDA says

The Federal Drug Administration has announced the recall of over 580,000 bottles of a blood pressure medication due to concerns over potential cancer-causing chemicals. Teva Pharmaceuticals USA and Amerisource Health Services voluntarily recalled various strengths of prazosine capsules, which are used to relax blood vessels and improve blood flow. The capsules, available in 1 mg, 2 mg, and 5 mg doses, are sometimes prescribed for individuals experiencing nightmares and sleep disturbances related to post-traumatic stress disorder.

The FDA classified the affected lots of the recalled drug as a Class II risk, citing the presence of nitrosamine impurities that are considered potentially carcinogenic. Nitrosamines can form during the manufacturing or storage of a drug, posing a risk to consumers. Teva Pharmaceuticals has yet to provide a comment on the recall.

It is crucial for individuals who may be taking prazosine capsules to check the lot numbers of their medication and consult with their healthcare provider if they have any concerns. The FDA recommends following the recall orders posted on their website to ensure the safe use of the medication.

For more updates and news on health-related issues, stay tuned to CBS News for the latest updates.